Clinical trial
Pharmacokinetics of Drospirenone Only Pills in Obese Thai Women: A Pre- and Post-Bariatric Surgery Study
Name
077766
Description
The purpose of this study is to investigate whether bariatric surgery affects Drospirenone only pills absorption
Trial arms
Trial start
2024-04-01
Estimated PCD
2025-04-01
Trial end
2025-04-01
Status
Not yet recruiting
Phase
Early phase I
Treatment
Drospirenone
4 mg tablet once daily
Arms:
Drospirenone
Size
16
Primary endpoint
Plasma concentration versus Time of Drospirenone
1 month before and 1 month after bariatric surgery
Eligibility criteria
Inclusion Criteria:
* Thai women aged 18-45 years who are obese and had an appointment for Bariatric surgery at Chulalongkorn Hospital
* Need contraception
* Able to use non-hormonal contraception during the study
* Giving consent
Exclusion Criteria:
* Pregnancy or history of giving birth within 3 months
* Breastfeeding within the 6 months
* History of using DMPA within 12 months
* History of using other types of hormonal birth control pills within 4 weeks
* History of bilateral oophorectomy or hysterectomy
* Suspected ovarian tumor or pathological ovarian cyst
* Regular cigarette smoking
* Contraindications to Drospirenone
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['PHASE1', 'PHASE2'], 'designInfo': {'allocation': 'NA', 'interventionModel': 'SINGLE_GROUP', 'interventionModelDescription': 'Pre-bariatric surgery pharmacokinetics study of Drospirenone compare with post-bariatric surgery', 'primaryPurpose': 'BASIC_SCIENCE', 'maskingInfo': {'masking': 'NONE'}}, 'enrollmentInfo': {'count': 16, 'type': 'ESTIMATED'}}
Updated at
2024-04-03
1 organization
1 product
1 indication
Organization
Chulalongkorn UniversityProduct
DrospirenoneIndication
Contraception